ICI Europe Summit 2018

ICI Europe Summit
Evidencing How Checkpoint Combinations Can Enhance Every Stage of the Cancer Immunity Cycle
27-29 November 2018 | Berlin, Germany
Website: https://bit.ly/2DHoGu6

Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development. Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.

Don’t miss this opportunity to join Merck, Genentech, AstraZeneca, Bayer, Roche and many other leading organisations, to empower you to make the right decisions with your IO pipeline and lay the foundations for your future success.
Access the complete programme to find out more about the speakers and what they will discuss: https://bit.ly/2DwHn3P

MabDesign members have 20% discount when registering. Contact us to obtain your code!

Date

27-29 November 2018

Lieu

Berlin, Germany

Organisateur

Hanson Wade